Pharmaceutical Compositions Comprising Human Antibodies To Pcsk9

Abstract

The present invention further relates to methods of testing the efficacy of PCSK9-specific antibodies or antigen-binding fragments thereof for the treatment of certain diseases or conditions and for the treatment of specific sub-groups of patients.


Claims
Owners (US)
CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jun 20, 2017
  • Application: Jan 27, 2012
    US US 201213982381 A
  • Priority: Jan 27, 2012
    EP EP 2012051321 W
  • Priority: Nov 8, 2011
    EP EP 11306449 A
  • Priority: Nov 8, 2011
    EP EP 11306450 A
  • Priority: Sep 22, 2011
    EP EP 11306201 A
  • Priority: Sep 22, 2011
    EP EP 11306202 A
  • Priority: Aug 12, 2011
    EP EP 11306039 A
  • Priority: Aug 12, 2011
    EP EP 11306040 A
  • Priority: Apr 29, 2011
    EP EP 11305513 A
  • Priority: Apr 29, 2011
    EP EP 11305514 A
  • Priority: Jan 28, 2011
    EP EP 11305088 A
  • Priority: Jan 28, 2011
    EP EP 11305089 A

Download Citation


Sign in to the Lens

Feedback